These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8151006)

  • 1. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M; Castillo J; Pope HG; Herbstein J
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment guidelines for valproate in bipolar and schizoaffective disorders.
    McElroy SL; Keck PE
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S62-6. PubMed ID: 8500081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.
    Stoll AL; Banov M; Kolbrener M; Mayer PV; Tohen M; Strakowski SM; Castillo J; Suppes T; Cohen BM
    J Clin Psychopharmacol; 1994 Oct; 14(5):311-3. PubMed ID: 7806685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate in psychiatric disorders: literature review and clinical guidelines.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychiatry; 1989 Mar; 50 Suppl():23-9. PubMed ID: 2494155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term response to carbamazepine: a retrospective study.
    Frankenburg FR; Tohen M; Cohen BM; Lipinski JF
    J Clin Psychopharmacol; 1988 Apr; 8(2):130-2. PubMed ID: 3372707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital.
    Steckler TL
    J Clin Psychopharmacol; 1994 Oct; 14(5):336-9. PubMed ID: 7806689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate in the treatment of posttraumatic bipolar disorder in a psychogeriatric patient.
    Yassa R; Cvejic J
    J Geriatr Psychiatry Neurol; 1994; 7(1):55-7. PubMed ID: 8192831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing strategies and time course of response to antimanic drugs.
    Bowden CL
    J Clin Psychiatry; 1996; 57 Suppl 13():4-9; discussion 10-2. PubMed ID: 8970500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine in severe mood disorders.
    Zarate CA; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenomenology of rapid cycling manic depression and its treatment with valproate.
    Calabrese JR; Delucchi GA
    J Clin Psychiatry; 1989 Mar; 50 Suppl():30-4. PubMed ID: 2494157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.